Suchergebnisse - "Ravetch, Jeffrey V"

PubPharm (394)

31

ANTIBODIES AND METHODS FOR TREATMENT OF VIRAL INFECTIONS

enthalten in: Europäisches Patentamt | 2022

von RAVETCH JEFFREY V | BOURNAZOS STYLIANOS

32

MODULATING AGONISTIC TNFR ANTIBODIES

enthalten in: Europäisches Patentamt | 2022

von LI FUBIN | RAVETCH JEFFREY V

33

PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine

enthalten in: Nature immunology | 2022

von Herati, R. | Knorr, D. | Vella, L. | +25

CommentIn: Nat Immunol. 2022 Aug;23(8):1135-1137. - PMID 35902636

34

A novel mouse strain optimized for chronic human antibody administration

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2022

von Gupta, A. | Smith, P. | Bournazos, S. | +1

35

Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy

enthalten in: Nature | 2021

von Yamin, R. | Jones, A. | Hoffmann, H. | +8

UpdateOf: Res Sq. 2021 May 27;:. - PMID 34075373

36

One-Pot Conversion of Free Sialoglycans to Functionalized Glycan Oxazolines and Efficient Synthesis of Homogeneous Antibody-Drug Conjugates through Site-Specific Chemoenzymatic Glycan Remodeling

enthalten in: Bioconjugate chemistry | 2021

von Ou, C. | Li, C. | Zhang, R. | +7

37

enthalten in: Europäisches Patentamt | 2021

von RAVETCH JEFFREY V | WANG TAIA | MAMAARY JAD

38

enthalten in: Europäisches Patentamt | 2021

von RAVETCH JEFFREY V | WANG TAIA | MAMAARY JAD

39

Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2021

von Ibarlucea-Benitez, I. | Weitzenfeld, P. | Smith, P. | +1

40

Antibody fucosylation predicts disease severity in secondary dengue infection

enthalten in: Science (New York, N.Y.) | 2021

von Bournazos, S. | Vo, H. | Duong, V. | +6

CommentIn: Science. 2021 Jun 4;372(6546):1041-1042. - PMID 34083476